The minimally invasive procedure, called fractional flow reserve — computed tomography, calculates how much blood is flowing through the coronary arteries by using data from 3D model scans of a patient’s heart, according to a Dec. 17 news release.
“Until now, the functional significance of heart artery blockages and the need for angioplasty and stents required invasive cardiac catheterization,” Mitchell Baruchin, MD, attending cardiologist and co-director of the Echo Lab, said in the release. “FFR-CT is the only non-invasive test that can both see artery blockages as well as check for impact on blood flow. It’s FDA approved and covered by insurance.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
